Opthea Ltd (OPT) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.460x

Based on the latest financial reports, Opthea Ltd (OPT) has a cash flow conversion efficiency ratio of 0.460x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-92.00 Million ≈ $-65.10 Million USD) by net assets (AU$-200.16 Million ≈ $-141.63 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see OPT company net worth for the company's overall valuation and market capitalisation.

Opthea Ltd - Cash Flow Conversion Efficiency Trend (1991–2025)

This chart illustrates how Opthea Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Opthea Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Opthea Ltd ranked by their cash flow conversion efficiency. Explore OPT operating cash flow to net income to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Real Heart
ST:HEART
-0.026x
Titan Logix Corp.
V:TLA
-0.028x
Scottish American Investment Co
LSE:SAIN
0.015x
Taitron Components Incorporated
NASDAQ:TAIT
0.026x
Megalestari Epack Sentosaraya Pt
JK:EPAC
0.086x
Mint Incorporation Limited Class A Ordinary Shares
NASDAQ:MIMI
N/A
BIGG Digital Assets Inc
F:7111
-0.096x
Supreme Engineering Limited
NSE:SUPREMEENG
-0.011x

Annual Cash Flow Conversion Efficiency for Opthea Ltd (1991–2025)

The table below shows the annual cash flow conversion efficiency of Opthea Ltd from 1991 to 2025. View Opthea Ltd share price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$-201.07 Million
≈ $-142.27 Million
AU$-158.64 Million
≈ $-112.25 Million
0.789x -62.85%
2024-06-30 AU$-75.81 Million
≈ $-53.64 Million
AU$-161.02 Million
≈ $-113.93 Million
2.124x -89.58%
2023-06-30 AU$-8.79 Million
≈ $-6.22 Million
AU$-179.30 Million
≈ $-126.87 Million
20.391x +1546.31%
2022-06-30 AU$69.77 Million
≈ $49.37 Million
AU$-98.37 Million
≈ $-69.60 Million
-1.410x -316.10%
2021-06-30 AU$180.20 Million
≈ $127.50 Million
AU$-61.06 Million
≈ $-43.20 Million
-0.339x -166.36%
2020-06-30 AU$64.81 Million
≈ $45.86 Million
AU$-8.24 Million
≈ $-5.83 Million
-0.127x +83.63%
2019-06-30 AU$31.12 Million
≈ $22.02 Million
AU$-24.19 Million
≈ $-17.11 Million
-0.777x -48.80%
2018-06-30 AU$38.17 Million
≈ $27.01 Million
AU$-19.94 Million
≈ $-14.11 Million
-0.522x -370.79%
2017-06-30 AU$54.49 Million
≈ $38.56 Million
AU$-6.05 Million
≈ $-4.28 Million
-0.111x +54.86%
2016-06-30 AU$14.98 Million
≈ $10.60 Million
AU$-3.68 Million
≈ $-2.60 Million
-0.246x +18.54%
2015-06-30 AU$16.66 Million
≈ $11.79 Million
AU$-5.03 Million
≈ $-3.56 Million
-0.302x +28.69%
2014-06-30 AU$9.87 Million
≈ $6.98 Million
AU$-4.17 Million
≈ $-2.95 Million
-0.423x +1.23%
2013-06-30 AU$13.10 Million
≈ $9.27 Million
AU$-5.61 Million
≈ $-3.97 Million
-0.428x -23.41%
2012-06-30 AU$20.67 Million
≈ $14.62 Million
AU$-7.17 Million
≈ $-5.08 Million
-0.347x +14.02%
2011-06-30 AU$23.32 Million
≈ $16.50 Million
AU$-9.42 Million
≈ $-6.66 Million
-0.404x -44.72%
2010-06-30 AU$27.04 Million
≈ $19.13 Million
AU$-7.54 Million
≈ $-5.34 Million
-0.279x -32.46%
2009-06-30 AU$31.29 Million
≈ $22.14 Million
AU$-6.59 Million
≈ $-4.66 Million
-0.211x -475.98%
2008-06-30 AU$49.18 Million
≈ $34.80 Million
AU$-1.80 Million
≈ $-1.27 Million
-0.037x -105.73%
2007-06-30 AU$51.71 Million
≈ $36.59 Million
AU$32.97 Million
≈ $23.33 Million
0.638x +1028.75%
2006-06-30 AU$42.07 Million
≈ $29.77 Million
AU$-2.89 Million
≈ $-2.04 Million
-0.069x -20.11%
2005-06-30 AU$28.63 Million
≈ $20.26 Million
AU$-1.64 Million
≈ $-1.16 Million
-0.057x +2.50%
2004-06-30 AU$29.15 Million
≈ $20.63 Million
AU$-1.71 Million
≈ $-1.21 Million
-0.059x -31.10%
2002-06-30 AU$23.28 Million
≈ $16.47 Million
AU$-1.04 Million
≈ $-736.53K
-0.045x -7.66%
2001-06-30 AU$24.20 Million
≈ $17.12 Million
AU$-1.01 Million
≈ $-711.19K
-0.042x +87.30%
1997-06-30 AU$5.32 Million
≈ $3.77 Million
AU$-1.74 Million
≈ $-1.23 Million
-0.327x -3.21%
1996-06-30 AU$3.83 Million
≈ $2.71 Million
AU$-1.22 Million
≈ $-859.69K
-0.317x +2.21%
1995-06-30 AU$2.07 Million
≈ $1.47 Million
AU$-672.00K
≈ $-475.48K
-0.324x -44.64%
1994-06-30 AU$2.09 Million
≈ $1.48 Million
AU$-469.00K
≈ $-331.85K
-0.224x -3.14%
1993-06-30 AU$1.62 Million
≈ $1.14 Million
AU$-351.00K
≈ $-248.35K
-0.217x -32.60%
1992-06-30 AU$1.63 Million
≈ $1.15 Million
AU$-267.00K
≈ $-188.92K
-0.164x -7.51%
1991-06-30 AU$1.29 Million
≈ $914.88K
AU$-197.00K
≈ $-139.39K
-0.152x --

About Opthea Ltd

AU:OPT Australia Biotechnology
Market Cap
$9.68 Million
AU$13.68 Million AUD
Market Cap Rank
#27254 Global
#1311 in Australia
Share Price
AU$0.01
Change (1 day)
-9.09%
52-Week Range
AU$0.01 - AU$0.60
All Time High
AU$3.47
About

Opthea Limited, a clinical-stage biopharmaceutical company, researches and develops therapeutic products based on targeting vascular endothelial growth factors (VEGF) C, D and R3 in Australia and the United States. The company's pipeline includes Sozinibercept, which is in phase 3 to treat wet age-related macular degeneration (Wet AMD), as well as in phase 2 to treat diabetic macular edema (DME).… Read more